Stay updated on XEN801 Topical Gel Clinical Trial
Sign up to get notified when there's something new on the XEN801 Topical Gel Clinical Trial page.

Latest updates to the XEN801 Topical Gel Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a consolidated Locations section listing province-level study sites (Alberta, British Columbia, Manitoba, New Brunswick, Ontario, Quebec) and updated to revision v3.3.3; removed the prior province-specific location subsections.SummaryDifference0.7%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision in the page footer updated from v3.2.0 to v3.3.2 (Revision: v3.3.2); this is a minor software version update and does not change the study details, navigation, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoved a generic operating-status notice about government funding from the page; no study information or criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedThe new screenshot shows only cosmetic layout adjustments and formatting changes on the Study Details page; the core study data (title, status, enrollment, criteria, and endpoints) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check88 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference5%

- Check96 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the page.SummaryDifference0.6%

Stay in the know with updates to XEN801 Topical Gel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN801 Topical Gel Clinical Trial page.